James O. Wilson

Array ( [id] => 4156293 [patent_doc_number] => 06124445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Phosphotriester oligonucleotides, amidities and method of preparation' [patent_app_type] => 1 [patent_app_number] => 9/004940 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13590 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124445.pdf [firstpage_image] =>[orig_patent_app_number] => 004940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173666 [patent_doc_number] => 06036946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Methods for protecting skin from damaging effects of ultraviolet light' [patent_app_type] => 1 [patent_app_number] => 8/998238 [patent_app_country] => US [patent_app_date] => 1997-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/036/06036946.pdf [firstpage_image] =>[orig_patent_app_number] => 998238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306716 [patent_doc_number] => 06187913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Covalently crosslinked oligonucleotides, preparation method and synthon which is of use in the method' [patent_app_type] => 1 [patent_app_number] => 8/930500 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5653 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187913.pdf [firstpage_image] =>[orig_patent_app_number] => 930500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326280 [patent_doc_number] => 06329346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Oligo-2\'-deoxynucleotides and their use as pharmaceutical agents with antiviral activity' [patent_app_type] => 1 [patent_app_number] => 8/991183 [patent_app_country] => US [patent_app_date] => 1997-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13004 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329346.pdf [firstpage_image] =>[orig_patent_app_number] => 991183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4386605 [patent_doc_number] => 06262252 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Single-step method for labeling nucleic acids with mustard or aziridine labeling reagents' [patent_app_type] => 1 [patent_app_number] => 8/982485 [patent_app_country] => US [patent_app_date] => 1997-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 9884 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262252.pdf [firstpage_image] =>[orig_patent_app_number] => 982485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185204 [patent_doc_number] => 06159951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => '2\'-O-amino-containing nucleoside analogs and polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/982841 [patent_app_country] => US [patent_app_date] => 1997-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9971 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159951.pdf [firstpage_image] =>[orig_patent_app_number] => 982841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996302 [patent_doc_number] => 05919916 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => '6-O-alkyl derivatives of erythronolide B' [patent_app_type] => 1 [patent_app_number] => 8/980919 [patent_app_country] => US [patent_app_date] => 1997-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4443 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919916.pdf [firstpage_image] =>[orig_patent_app_number] => 980919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004265 [patent_doc_number] => 06004938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Inositolglycans having insulin-like action' [patent_app_type] => 1 [patent_app_number] => 8/979865 [patent_app_country] => US [patent_app_date] => 1997-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6510 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 404 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004938.pdf [firstpage_image] =>[orig_patent_app_number] => 979865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322537 [patent_doc_number] => 06248878 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Nucleoside analogs' [patent_app_type] => 1 [patent_app_number] => 8/975238 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12819 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248878.pdf [firstpage_image] =>[orig_patent_app_number] => 975238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3967325 [patent_doc_number] => 05886037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Nutritional composition for the treatment of hypertriglyceridaemia and hyperchylomicronaemia' [patent_app_type] => 1 [patent_app_number] => 8/975074 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2964 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886037.pdf [firstpage_image] =>[orig_patent_app_number] => 975074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109341 [patent_doc_number] => 06022959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/975522 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16858 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022959.pdf [firstpage_image] =>[orig_patent_app_number] => 975522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185078 [patent_doc_number] => 06020480 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Caged NADP and NAD' [patent_app_type] => 1 [patent_app_number] => 8/974434 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 8420 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/020/06020480.pdf [firstpage_image] =>[orig_patent_app_number] => 974434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4422144 [patent_doc_number] => 06177558 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Method and composition for chemical synthesis using high boiling point organic solvents to control evaporation' [patent_app_type] => 1 [patent_app_number] => 8/970115 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5396 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177558.pdf [firstpage_image] =>[orig_patent_app_number] => 970115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4062307 [patent_doc_number] => 06007992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Pyrimidine derivatives for labeled binding partners' [patent_app_type] => 1 [patent_app_number] => 8/966875 [patent_app_country] => US [patent_app_date] => 1997-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30789 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007992.pdf [firstpage_image] =>[orig_patent_app_number] => 966875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209914 [patent_doc_number] => 06028183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Pyrimidine derivatives and oligonucleotides containing same' [patent_app_type] => 1 [patent_app_number] => 8/966392 [patent_app_country] => US [patent_app_date] => 1997-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30772 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028183.pdf [firstpage_image] =>[orig_patent_app_number] => 966392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772663 [patent_doc_number] => 05807840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Method for treating canine distemper' [patent_app_type] => 1 [patent_app_number] => 8/963849 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2068 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807840.pdf [firstpage_image] =>[orig_patent_app_number] => 963849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951884 [patent_doc_number] => 20020006913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'ANTIMUTAGENIC COMPOSITIONS FOR TREATMENT AND PREVENTION OF PHOTODAMAGE TO SKIN' [patent_app_type] => new [patent_app_number] => 08/963831 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11332 [patent_no_of_claims] => 143 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006913.pdf [firstpage_image] =>[orig_patent_app_number] => 08963831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4219303 [patent_doc_number] => 06111096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-29 [patent_title] => 'Nucleic acid isolation and purification' [patent_app_type] => 1 [patent_app_number] => 8/962280 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 10538 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/111/06111096.pdf [firstpage_image] =>[orig_patent_app_number] => 962280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006551 [patent_doc_number] => 05859232 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Process for the synthesis of oligomeric phosphite, phosphodiester, phosphorothioate and phosphorodithioate compounds' [patent_app_type] => 1 [patent_app_number] => 8/962175 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16786 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859232.pdf [firstpage_image] =>[orig_patent_app_number] => 962175 [rel_patent_id] =>[rel_patent_doc_number] =>)